Key result
A specialized Women's Heart Center focusing on coronary microvascular and vasomotor dysfunction saw 3,219 patients from October 2020 to December 2023, with 42% participating in the CMVD program.
Why the study?
Women's Heart Centers are designed to close the existing gap in women's cardiovascular care, but models for establishing and growing specialized coronary microvascular and vasomotor dysfunction programs need description.
Establishing a specialized Women's Heart Center focused on coronary microvascular and vasomotor dysfunction can successfully attract a large and growing patient volume.
BACKGROUND: Women's Heart Centers (WHC) are comprehensive, multidisciplinary care centers designed to close the existing gap in women's cardiovascular care. The WHC at The Christ Hospital Heart and Vascular Institute (TCH-WHC) in Cincinnati, Ohio was established in October of 2020, and is a specialized coronary microvascular and vasomotor dysfunction (CMVD) program. METHODS: The TCH-WHC focuses its efforts across five pillars: patient care, research, education, community outreach and advocacy, and grants and philanthropy. These areas, centered around providing specalized CMVD care and treatment have allowed for substantial growth. RESULTS: From October 2020-December 2023, TCH-WHC saw a total of 3219 patients, 42% of which were apart of the CMVD program. Since establishment, patient volume has consistently increased year over year. CONCLUSION: The CMVD program at TCH-WHC is one of the fastest growing in the U. S. and is nationally recognized for specialized clinical care, diagnostics, and research. The goal of this review is to provide an overview of the TCH-WHC structure that allows for the establishment and growth of a CMVD program and to outline core activities supporting the TCH-WHC approach.
No takes yet. Share an insight, caveat, or question.
Tapp et al. (2024) conducted a review in Coronary microvascular and vasomotor dysfunction (n=3,219). Women's Heart Center specialized in CMVD was evaluated on Patient volume. A specialized Women's Heart Center focusing on coronary microvascular and vasomotor dysfunction saw 3,219 patients from October 2020 to December 2023, with 42% participating in the CMVD program.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: